WEGOVY

Description

Wegovy is a once-weekly weight loss injection designed to support adults in their weight loss journey. It contains semaglutide, a highly effective active ingredient that helps reduce appetite, regulate blood sugar levels, and support healthy digestion. Wegovy can help patients lose an average of 15% of their body weight by mimicking natural hormones to curb hunger and manage blood sugar. This trusted treatment is available in the UK through an online clinical consultation at UK Meds, with prescriptions provided by registered independent prescribers.

Active ingredient: Each 0.5mg dose contains semaglutide, a GLP-1 analogue produced via recombinant DNA technology in Saccharomyces cerevisiae.

Therapeutic effect: Promotes weight loss by reducing appetite, increasing satiety, and lowering caloric intake.

BUY WEIGHT LOSS MEDS IN UK

Key Features:

Dose Precision: Delivers four individual doses of 0.5mg semaglutide per pen.

Weekly Administration: Supports long-term weight management with once-weekly dosing.

Clinically Proven: Demonstrated average body weight reduction of 9.6% over 68 weeks in adults with type 2 diabetes.

Common Side Effects:

Nausea (43.9%)
Diarrhoea (29.7%)
Constipation (24.2%)
Vomiting (24.5%)
Headache, dizziness, and increased heart rate.
Serious Risks:
Acute pancreatitis (0.2%)
Cholelithiasis (1.6%) and cholecystitis (0.6%)
Hair loss (2.5%) and injection site reactions